•  

St. Michael’s Hospital

Dr. Kamran Khan, founder of BioDiaspora, among experts studying emergence of coronavirus

Health risk to Canadians is currently low Dr. Kamran Khan, founder of BioDiaspora and an infectious disease physician and scientist at St. Michael's Hospital, is among the experts studying the emergence of the coronavirus. Carolyn Brown interviewed Khan for a recent CMAJ article on the viral outbreak, "New coronavirus with 'pandemic potential' sparks global surveillance efforts." (more…) Read more

What does MaRS Innovation’s funding extension mean for Toronto’s academic entrepreneurs?

Every six weeks, MaRS Innovation's marketing and communications manager writes a guest post for the MaRS Discovery District blog profiling MI's activities or one of our start-up companies. You can read the original post on the MaRS blog. Created in 2008, MaRS Innovation (MI) bridges the chasm between the early-stage technologies emerging from its 16 member institutions and successful startup companies and licensable technologies. By offering early-stage funding in tandem with hands-on management, business development, mentorship and intellectual property protection strategy, MI acts as ... Read more

BioDiaspora Founder Kamran Khan interviewed in Maclean’s Magazine

India's Kumbh Mela, an annual mass Hindu pilgrimage of faith, is unlikely to create a disease outbreak that spreads beyond the country's borders, Dr. Kamran Khan, founder of BioDiaspora, tells Maclean's Magazine's Hannah Hoag in "As millions gather for Kumbh Mela, doctors are watching" (February 11, 2013). Here's an excerpt (emphasis ours): Unlike the hajj or the Olympics, the Kumbh Mela is primarily a domestic event. While flights into Saudi Arabia spike to five times normal during the hajj, “with the Kumbh Mela, ... Read more

MaRS Innovation awarded $15 million to further commercialize world-leading Canadian innovations

Networks of Centres of Excellence recognizes strength of partnership between MI and its 16 member institutions TORONTO, February 5, 2013 — How do you make sure the brilliant ideas emerging from Toronto’s academic research community get the best possible chance to succeed? MaRS Innovation (MI), created in 2008, bridges the chasm between these early-stage technologies and successful start-up companies and licensable technologies. By offering early-stage funding in tandem with hands-on management, mentorship and IP strategy protection, MI acts as a commercialization agent for ... Read more
Page 3 of 3123